Publications April 4, 2017 – Articles Ohio Governor Announces New Opiate Prescribing Limitations Daniel S. Zinsmaster, Thomas W. Hess December 27, 2016 – Articles Unintended Consequences of Ohio's S.B. 319 Could Reduce Access to Addiction Treatment Eric J. Plinke and Daniel S. Zinsmaster December 2, 2016 – Articles Effective December 1, Pharmacies, Prescribers, and Wholesalers Must Report Gabapentin to OARRS Eric J. Plinke and Daniel S. Zinsmaster October 10, 2016 – Articles HHS Issues New Reporting Requirements for Practitioners Treating Opioid Addiction Daniel S. Zinsmaster, Courtney M. White June 20, 2016 – Articles Deadline Extended for Sole Proprietors to Register with Board of Pharmacy as Terminal Distributors of Dangerous Drugs Eric J. Plinke and Daniel S. Zinsmaster June 16, 2016 – Articles New AMA Guidelines for Telemedicine: Informed Consent and Health Information Security Essential Daniel S. Zinsmaster April 29, 2016 – Articles New Board of Pharmacy Regulations Significantly Narrow the Sole Proprietor Exemption and Impose New Compounding Standards Eric J. Plinke and Daniel S. Zinsmaster April 22, 2016 – Articles Ohio Following National Trend in Clarifying Permissible Telemedicine Activities April 4, 2016 – Articles Proposed Rule Seeks to Increase Access to Treatment for Opioid and Heroin Abuse Eric J. Plinke and Daniel S. Zinsmaster March 16, 2016 – Articles CDC Releases First National Standards Regarding Prescription Painkillers Daniel S. Zinsmaster August 7, 2015 – Articles Ohio’s New OARRS Standards and Procedures Eric J. Plinke, Daniel S. Zinsmaster June 16, 2015 – Articles Physician Compensation Arrangements See Increased OIG Scrutiny Daniel S. Zinsmaster Page 3 of 3 Previous
April 4, 2017 – Articles Ohio Governor Announces New Opiate Prescribing Limitations Daniel S. Zinsmaster, Thomas W. Hess
December 27, 2016 – Articles Unintended Consequences of Ohio's S.B. 319 Could Reduce Access to Addiction Treatment Eric J. Plinke and Daniel S. Zinsmaster
December 2, 2016 – Articles Effective December 1, Pharmacies, Prescribers, and Wholesalers Must Report Gabapentin to OARRS Eric J. Plinke and Daniel S. Zinsmaster
October 10, 2016 – Articles HHS Issues New Reporting Requirements for Practitioners Treating Opioid Addiction Daniel S. Zinsmaster, Courtney M. White
June 20, 2016 – Articles Deadline Extended for Sole Proprietors to Register with Board of Pharmacy as Terminal Distributors of Dangerous Drugs Eric J. Plinke and Daniel S. Zinsmaster
June 16, 2016 – Articles New AMA Guidelines for Telemedicine: Informed Consent and Health Information Security Essential Daniel S. Zinsmaster
April 29, 2016 – Articles New Board of Pharmacy Regulations Significantly Narrow the Sole Proprietor Exemption and Impose New Compounding Standards Eric J. Plinke and Daniel S. Zinsmaster
April 22, 2016 – Articles Ohio Following National Trend in Clarifying Permissible Telemedicine Activities
April 4, 2016 – Articles Proposed Rule Seeks to Increase Access to Treatment for Opioid and Heroin Abuse Eric J. Plinke and Daniel S. Zinsmaster
March 16, 2016 – Articles CDC Releases First National Standards Regarding Prescription Painkillers Daniel S. Zinsmaster
August 7, 2015 – Articles Ohio’s New OARRS Standards and Procedures Eric J. Plinke, Daniel S. Zinsmaster
June 16, 2015 – Articles Physician Compensation Arrangements See Increased OIG Scrutiny Daniel S. Zinsmaster